Drug
SU
SU is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown360%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
completed
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
NCT05073692
completednot_applicable
SU Versus GD for Sperm Preparation in IUI
NCT04477356
unknown
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
NCT05161429
unknownnot_applicable
Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
NCT03180281
unknownphase_2
Neurofeedback Study ADHD
NCT01879644
Clinical Trials (5)
Showing 5 of 5 trials
NCT05073692
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
NCT04477356Not Applicable
SU Versus GD for Sperm Preparation in IUI
NCT05161429
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
NCT03180281Not Applicable
Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
NCT01879644Phase 2
Neurofeedback Study ADHD
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5